Communiqués Artivion, Inc.

Actions

AORT

US2289031005

Equipement, fournitures et distribution médicale

Marché Fermé - NYSE Autres places de cotation 22:00:02 27/07/2026			Varia. 5j.	Varia. 1 janv.
26,10 ^USD	+3,24%		+2,88%	-42,78%

29/06	Artivion obtient l'homologation de la FDA pour sa prothèse hybride ; le titre grimpe en avant-bourse	MT
29/06	Artivion reçoit l'approbation de la FDA pour sa prothèse hybride AMDS	CI

Communiqués

23/07	Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2026 Financial Results	PR
29/06	Artivion Announces U.S. FDA Approval of the AMDS Hybrid Prosthesis	PR
10/06	Artivion to Participate in the 2026 Truist Securities MedTech Conference	PR
18/05	Endospan Announces Closing of Acquisition by Artivion, Inc., Following FDA PMA Approval of the NEXUS® Aortic Arch System	BU
18/05	Artivion Completes Acquisition of Endospan Ltd.	PR
07/05	Artivion: Q1 Earnings Snapshot	AQ
07/05	Artivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to Acquire Endospan	PR
23/04	Artivion Announces Release Date and Teleconference Call Details for First Quarter 2026 Financial Results	PR
07/04	Artivion Announces U.S. FDA Approval of the NEXUS® Aortic Arch System	PR
03/03	Artivion to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference	PR
12/02	Artivion: Q4 Earnings Snapshot	AQ
12/02	Artivion Reports Fourth Quarter and Full Year 2025 Financial Results	PR
02/02	Artivion Announces Presentation of Positive New Clinical Data from NEXUS TRIOMPHE and AMDS PERSEVERE Trials at the 62nd Society of Thoracic Surgery Annual Meeting	PR
29/01	Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter 2025 Financial Results	PR
06/11	Artivion: Q3 Earnings Snapshot	AQ
06/11	Artivion Reports Third Quarter 2025 Financial Results	PR
06/11	Artivion Announces Treatment of First Patient with Arcevo LSA in ARTIZEN Pivotal Trial	PR
29/10/25	Artivion to Participate in the Stifel 2025 Healthcare Conference	PR
23/10/25	Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2025 Financial Results	PR
14/10/25	Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting	AQ
13/10/25	Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at the 39th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting	PR
05/09/25	Artivion to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference	PR
07/08/25	Artivion: Q2 Earnings Snapshot	AQ
07/08/25	Artivion Reports Second Quarter 2025 Financial Results	PR
30/07/25	Artivion to Participate in Upcoming Investor Conferences	PR